- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Anyang Tumor Hospital
Total 1804 results
-
Anyang Tumor HospitalUnknownEsophagogastric Junction CancerChina
-
Fudan UniversityAnyang Tumor HospitalNot yet recruiting
-
Hebei Tumor HospitalUnknown
-
Hebei Tumor HospitalUnknown
-
Hebei Tumor HospitalUnknown
-
Hebei Tumor HospitalUnknown
-
Liaoning Tumor Hospital & InstituteNot yet recruitingNon Small Cell Lung Cancer
-
Hunan Province Tumor HospitalRecruiting
-
Hunan Province Tumor HospitalRecruitingAdvanced Solid Tumors or LymphomasChina
-
Hunan Province Tumor HospitalRecruitingExtensive-stage Small-cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruiting
-
Liaoning Tumor Hospital & InstituteNot yet recruitingDiffuse Large B Cell LymphomaChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung Cancer | ALK Gene Mutation | MET Gene Mutation | EGFR Gene Mutation | ROS1 Gene MutationChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Liaoning Tumor Hospital & InstituteNot yet recruitingTriple-negative Breast Cancer
-
Hunan Province Tumor HospitalRecruitingReal World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung CancerNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung Cancer | KRAS G12D | KRAS G12R | KRAS G12V | KRAS G12C | KRAS G12Y | KRAS G13NChina
-
Hunan Province Tumor HospitalCompletedNon-squamous NSCLCChina
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalUnknownNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedAdenocarcinoma | Non-small-cell Lung CancerChina
-
Hunan Province Tumor HospitalUnknownNasopharyngeal Carcinoma | Radiosensitivity | Single Nucleotide PolymorphismsChina
-
Hunan Province Tumor HospitalNot yet recruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruiting
-
Hunan Province Tumor HospitalRecruitingAdvanced Lung CancerChina
-
Hunan Province Tumor HospitalRecruiting
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingLung Adenocarcinoma | ALK Gene Mutation | ImmunotherapyChina
-
Liaoning Tumor Hospital & InstituteNot yet recruiting
-
Liaoning Tumor Hospital & InstituteNot yet recruitingNSCLC | EGF-R Positive Non-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruiting
-
Hunan Province Tumor HospitalRecruitingSmall-cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Liaoning Tumor Hospital & InstituteCompletedHER2-positive Metastatic Breast CancerChina
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompleted
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompleted